康泰医学
(300869)
| 流通市值：41.32亿 | | | 总市值：65.53亿 |
| 流通股本：2.53亿 | | | 总股本：4.02亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 737,467,276.65 | 747,382,470.78 | 684,307,771.48 | 602,394,001.29 |
| 交易性金融资产 | 642,752,724.31 | 672,307,189.11 | 171,588,083.19 | 610,916,579.69 |
| 应收票据及应收账款 | 39,604,096.77 | 45,683,043.03 | 45,998,781.84 | 42,185,451.66 |
| 应收账款 | 39,604,096.77 | 45,683,043.03 | 45,998,781.84 | 42,185,451.66 |
| 预付款项 | 11,926,516.26 | 9,570,191.8 | 6,178,488.89 | 8,585,704.82 |
| 其他应收款合计 | 21,182,006.78 | 13,127,983.6 | 7,341,827.52 | 15,408,410.61 |
| 存货 | 277,275,030.66 | 265,882,645.56 | 272,322,956.49 | 404,174,990.72 |
| 一年内到期的非流动资产 | 590,263,484.59 | 359,453,347.21 | 252,028,342.47 | 163,935,069.48 |
| 其他流动资产 | 20,910,099.88 | 31,339,708.67 | 481,453,009 | 4,135,867.61 |
| 流动资产合计 | 2,341,381,235.9 | 2,144,746,579.76 | 1,921,219,260.88 | 1,851,736,075.88 |
| 非流动资产: | | | | |
| 投资性房地产 | 59,621,815.82 | 6,555,703.44 | 8,265,877.77 | 14,402,512.19 |
| 固定资产 | 198,343,646.65 | 256,421,051 | 259,352,784.07 | 255,036,030.88 |
| 在建工程 | 89,318,209.48 | 73,556,675.43 | 72,847,298.84 | 54,639,534.76 |
| 使用权资产 | 3,019,096.67 | 3,377,867.15 | 3,867,651.58 | 4,231,778.53 |
| 无形资产 | 50,719,719.05 | 51,402,129.11 | 52,073,505.19 | 52,755,856.42 |
| 长期待摊费用 | 73,583.85 | 67,385.13 | 70,526.01 | 175,894.62 |
| 递延所得税资产 | 5,078,031.59 | 4,950,838.72 | 3,779,708.93 | 9,571,964.24 |
| 其他非流动资产 | 21,295,926.61 | 246,326,937.39 | 404,040,573.76 | 590,043,575.02 |
| 非流动资产合计 | 427,470,029.72 | 642,658,587.37 | 804,297,926.15 | 980,857,146.66 |
| 资产总计 | 2,768,851,265.62 | 2,787,405,167.13 | 2,725,517,187.03 | 2,832,593,222.54 |
| 流动负债: | | | | |
| 短期借款 | 165,000,000 | 91,436,896.37 | 60,000,000 | 90,000,000 |
| 应付票据及应付账款 | 22,772,574.24 | 14,451,777.63 | 18,393,772.57 | 15,555,862.78 |
| 应付账款 | 22,772,574.24 | 14,451,777.63 | 18,393,772.57 | 15,555,862.78 |
| 合同负债 | 34,517,114.42 | 42,556,014.33 | 32,036,930.34 | 36,440,198.91 |
| 应付职工薪酬 | 13,095,786.95 | 11,410,781.34 | 11,304,868.91 | 14,784,527.9 |
| 应交税费 | 5,601,405.82 | 5,899,560.77 | 1,528,862.75 | 8,643,580.67 |
| 其他应付款合计 | 3,334,501.45 | 5,312,203.14 | 10,105,860.34 | 6,533,174.09 |
| 一年内到期的非流动负债 | 1,135,904.15 | 1,312,021.13 | 1,418,205.79 | 1,477,447.32 |
| 流动负债合计 | 245,457,287.03 | 172,379,254.71 | 134,788,500.7 | 173,434,791.67 |
| 非流动负债: | | | | |
| 应付债券 | 740,255,459.52 | 731,806,196.59 | 723,521,709.93 | 715,132,644.65 |
| 租赁负债 | 1,642,150.31 | 1,486,762 | 1,834,700.4 | 2,549,007.42 |
| 递延收益 | 7,416,356.89 | 7,605,487.13 | 7,810,033.22 | 8,029,163.72 |
| 递延所得税负债 | 51,713.5 | 137,351.75 | 146,492.86 | - |
| 非流动负债合计 | 749,365,680.22 | 741,035,797.47 | 733,312,936.41 | 725,710,815.79 |
| 负债合计 | 994,822,967.25 | 913,415,052.18 | 868,101,437.11 | 899,145,607.46 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 401,802,977 | 401,802,977 | 401,802,977 | 401,802,765 |
| 其他权益工具 | 29,613,936.75 | 29,613,936.75 | 29,613,936.75 | 29,614,253.01 |
| 资本公积 | 352,340,023.82 | 352,340,023.82 | 352,340,023.82 | 345,146,203.51 |
| 其他综合收益 | 3,451,958.94 | 3,464,836.66 | 3,326,239.41 | 2,215,756.14 |
| 专项储备 | 3,469,428.06 | 3,469,428.06 | 3,469,428.06 | - |
| 盈余公积 | 174,456,618.55 | 174,456,618.55 | 174,456,618.55 | 174,456,618.55 |
| 未分配利润 | 808,893,355.25 | 908,842,294.11 | 892,406,526.33 | 980,212,018.87 |
| 归属于母公司股东权益合计 | 1,774,028,298.37 | 1,873,990,114.95 | 1,857,415,749.92 | 1,933,447,615.08 |
| 股东权益合计 | 1,774,028,298.37 | 1,873,990,114.95 | 1,857,415,749.92 | 1,933,447,615.08 |
| 负债和股东权益合计 | 2,768,851,265.62 | 2,787,405,167.13 | 2,725,517,187.03 | 2,832,593,222.54 |
| 公告日期 | 2025-08-29 | 2025-04-29 | 2025-04-29 | 2024-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |